{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:43:48Z","timestamp":1793313828303,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108791","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:50:55Z","timestamp":1753372255000},"page":"108791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Unveiling Tetrahydroberberine\u20131,3,4-Oxadiazole hybrids as potent anticancer agents and MMP-9 inhibitors with comprehensive insights from in silico, in vitro, and ex vivo permeation studies"],"prefix":"10.1016","volume":"163","author":[{"given":"Arbaz Sujat","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrilekha","family":"Chilvery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurav","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mourya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akansha Sanjayrao","family":"Ikhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka N.","family":"Makhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Rao","family":"Kaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108791_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.108791_bb0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/cancers14010238","article-title":"The functional role of extracellular matrix proteins in cancer","volume":"14","author":"Popova","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108791_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.896099","article-title":"Insights into the role of matrix metalloproteinases in cancer and its various therapeutic aspects: a review","volume":"9","author":"Mustafa","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2025.108791_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108791_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","article-title":"Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer","volume":"137","author":"Gonzalez-Avila","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0030","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.3892\/mmr.2015.4050","article-title":"B7-H3 promotes cell migration and invasion through the Jak2\/Stat3\/MMP9 signaling pathway in colorectal cancer","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2025.108791_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12029-009-9091-x","article-title":"Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma","volume":"40","author":"Buhmeida","year":"2009","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.bioorg.2025.108791_bb0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/bjc.2016.31","article-title":"A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer","volume":"114","author":"Annah\u00e1zi","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108791_bb0045","doi-asserted-by":"crossref","first-page":"1325095","DOI":"10.3389\/fonc.2023.1325095","article-title":"Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer","volume":"13","author":"Sampaio Moura","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127063","article-title":"Selective allosteric inhibition of MMP9 is efficacious in preclinical models of ulcerative colitis and colorectal cancer","volume":"10","author":"Marshall","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108791_bb0055","article-title":"Semisynthesis: bridging natural products and novel anticancer therapies","volume":"12","author":"Goel","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2025.108791_bb0060","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nrd2469","article-title":"Ixabepilone","volume":"6","author":"Conlin","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108791_bb0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.fitote.2012.04.012","article-title":"Phytochemical and pharmacological applications of Berberis aristata","volume":"83","author":"Potdar","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.108791_bb0070","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/S0031-9422(98)00121-6","article-title":"Isoquinoline alkaloids from Berberis vulgaris subsp. australis","volume":"49","author":"Suau","year":"1998","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2025.108791_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116143","article-title":"An insight into the medicinal attributes of berberine derivatives: a review","volume":"38","author":"Gaba","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/cbdd.12124","article-title":"Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells","volume":"81","author":"Ma","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108791_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejmech.2017.03.027","article-title":"Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents","volume":"132","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0090","doi-asserted-by":"crossref","first-page":"16205","DOI":"10.1021\/acs.jmedchem.1c01508","article-title":"Berberine molecular recognition of the parallel MYC G-quadruplex in solution","volume":"64","author":"Dickerhoff","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0095","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/molecules13122975","article-title":"Berberine suppresses TNF-\u03b1-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells","volume":"13","author":"Kim","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108791_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2009.06.023","article-title":"Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages","volume":"146","author":"Huang","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1039\/C4MD00264D","article-title":"Discovery of mitochondria-targeting berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells","volume":"6","author":"Fu","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2025.108791_bb0110","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/jps.10268","article-title":"P-glycoprotein\u2013mediated transport of berberine across Caco-2 cell monolayers","volume":"91","author":"Maeng","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108791_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/aps.2016.125","article-title":"Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system","volume":"38","author":"Zou","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2025.108791_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.108791_bb0125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpba.2015.07.031","article-title":"Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS\/MS","volume":"115","author":"Wang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2025.108791_bb0130","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1016\/j.bmc.2008.02.015","article-title":"Antioxidant and cytotoxic activities of canadine: biological effects and structural aspects","volume":"16","author":"Correch\u00e9","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/jm801157z","article-title":"Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105665","article-title":"Discovery and structural optimization of 9-O-phenylsulfonyl-berberines as new lipid-lowering agents","volume":"121","author":"Kong","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0145","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3762\/bjoc.16.133","article-title":"Synthesis of new dihydroberberine and tetrahydroberberine analogues and evaluation of their antiproliferative activity on NCI-H1975 cells","volume":"16","author":"Mari","year":"2020","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0155","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1158\/0008-5472.CAN-10-4552","article-title":"Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9","volume":"71","author":"Dufour","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108791_bb0160","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.bmcl.2018.04.028","article-title":"Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of mycobacterium tuberculosis","volume":"28","author":"Martinez-Grau","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108791_bb0165","doi-asserted-by":"crossref","first-page":"49311","DOI":"10.1021\/acsomega.3c07776","article-title":"Synthesis of some new 1,3,4-oxadiazole derivatives and evaluation of their anticancer activity","volume":"8","author":"Yurtta\u015f","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108791_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100373","article-title":"Design, synthesis, cytotoxic and enzyme inhibitory activities of 1,3,4-oxadiazole and 1,3,4-thiadiazine hybrids against non-small cell lung cancer","volume":"4","author":"Abdelsalam Ouf","year":"2022","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128697","article-title":"Exploration of mercaptoacetamide-linked pyrimidine-1,3,4-oxadiazole derivatives as DNA intercalative topo II inhibitors: cytotoxicity and apoptosis induction","volume":"65","author":"Shaikh","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105706","article-title":"Synthesis of indolo\/pyrroloazepinone-oxindoles as potential cytotoxic, DNA-intercalating and topo I inhibitors","volume":"122","author":"Kadagathur","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114465","article-title":"Design, synthesis of DNA-interactive 4-thiazolidinone-based indolo\u2212\/pyrroloazepinone conjugates as potential cytotoxic and topoisomerase I inhibitors","volume":"238","author":"Kadagathur","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0190","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1039\/D3MD00403A","article-title":"Development of trisubstituted thiophene-3-carboxamide selenide derivatives as novel EGFR kinase inhibitors with cytotoxic activity","volume":"14","author":"Makhal","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107677","article-title":"Synthesis, biological evaluation, and molecular docking studies of novel N-substituted piperazine-tethered thiophene-3-carboxamide selenides as potent antiproliferative agents with EGFR kinase inhibitory activity","volume":"151","author":"Makhal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3","article-title":"Morphologic and biochemical hallmarks of apoptosis","volume":"45","author":"Saraste","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bioorg.2025.108791_bb0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6750-5-12","article-title":"A simple technique for quantifying apoptosis in 96-well plates","volume":"5","author":"Ribble","year":"2005","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0210","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11626-015-9937-4","article-title":"Selenocystine-induced cell apoptosis and S-phase arrest inhibit human triple-negative breast cancer cell proliferation","volume":"51","author":"Long","year":"2015","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.bioorg.2025.108791_bb0215","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.bioorg.2025.108791_bb0220","article-title":"Clonogenic assay: adherent cells","volume":"49","author":"Rafehi","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioorg.2025.108791_bb0225","article-title":"Modified Annexin V\/Propidium iodide apoptosis assay for accurate assessment of cell death","volume":"59","author":"Rieger","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioorg.2025.108791_bb0230","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcp.21535","article-title":"Role of the hemopexin domain of matrix metalloproteinases in cell migration","volume":"217","author":"Dufour","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0235","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/acschembio.7b00758","article-title":"Targeting the hemopexin-like domain of latent matrix metalloproteinase-9 (proMMP-9) with a small molecule inhibitor prevents the formation of focal adhesion junctions","volume":"12","author":"Alford","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0240","first-page":"23","article-title":"Wound-healing assay","volume":"294","author":"Rodriguez","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0245","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cpt.1672","article-title":"Evaluating the role of solubility in oral absorption of poorly water-soluble drugs using physiologically based pharmacokinetic modeling","volume":"107","author":"Fink","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.108791_bb0250","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1158\/0008-5472.CAN-10-4552","article-title":"Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9","volume":"71","author":"Dufour","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108791_bb0255","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/acschembio.7b00758","article-title":"Targeting the hemopexin-like domain of latent matrix metalloproteinase-9 (proMMP-9) with a small molecule inhibitor prevents the formation of focal adhesion junctions","volume":"12","author":"Alford","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0260","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0265","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/jacsau.2c00085","article-title":"Describing chemical reactivity with frontier molecular orbitalets","volume":"2","author":"Yu","year":"2022","journal-title":"JACS Au"},{"key":"10.1016\/j.bioorg.2025.108791_bb0270","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.3390\/ijms222312827","article-title":"The mtt assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108791_bb0275","article-title":"Zein decorated rifaximin nanosuspension: approach for sustained release and anti-bacterial efficacy enhancement","volume":"16","author":"Mourya","year":"2024","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bioorg.2025.108791_bb0280","article-title":"Quality by design accredited self-nanoemulsifying delivery of ibrutinib for extenuating the fast-fed variability, ameliorating the anticancer activity and oral bioavailability in prostate cancer","volume":"89","author":"Shah","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioorg.2025.108791_bb0285","series-title":"Schr\u00f6dinger Release 2025-2: Induced Fit Docking protocol; Glide, Schr\u00f6dinger, LLC, New York, NY, 2024; Prime, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"key":"10.1016\/j.bioorg.2025.108791_bb0290","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108791_bb0295","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jmgm.2008.11.004","article-title":"Inside the Hsp90 inhibitors binding mode through induced fit docking","volume":"27","author":"Lauria","year":"2009","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2025.108791_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131077","article-title":"Computational approaches for decoding select odorant-olfactory receptor interactions using mini-virtual screening","volume":"10","author":"Harini","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108791_bb0305","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/molecules25071622","article-title":"Structure-based site of metabolism (SOM) prediction of ligand for CYP3A4 enzyme: comparison of glide XP and induced fit docking (IFD)","volume":"25","author":"Lokwani","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108791_bb0310","series-title":"Large-scale electronic structure calculations of high-Z metals on the BlueGene\/L platform, Proc. 2006 ACM\/IEEE Conf. Supercomput. (SC'06)","author":"Gygi","year":"2006"},{"key":"10.1016\/j.bioorg.2025.108791_bb0315","series-title":"Schr\u00f6dinger Release 2025-2: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2024; Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY","year":"2025"},{"key":"10.1016\/j.bioorg.2025.108791_bb0320","series-title":"Schr\u00f6dinger Release 2025\u20132: Jaguar, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"key":"10.1016\/j.bioorg.2025.108791_bb0325","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1080\/07391102.2019.1674695","article-title":"Molecular docking and molecular dynamics simulation studies to identify potent AURKA inhibitors: assessing the performance of density functional theory, MM-GBSA and mass action kinetics calculations","volume":"38","author":"Chinnasamy","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108791_bb0330","series-title":"Schr\u00f6dinger Release 2025\u20132: QikProp, Schr\u00f6dinger, LLC, New York, NY","year":"2025"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:56:12Z","timestamp":1776920172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":66,"alternative-id":["S0045206825006716"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108791","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling Tetrahydroberberine\u20131,3,4-Oxadiazole hybrids as potent anticancer agents and MMP-9 inhibitors with comprehensive insights from in silico, in vitro, and ex vivo permeation studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108791"}}